AVA Genomics Consultancy ApS: Financial statements 2020
CVR: 37493678
Source: annual report 2020, Danish Business Authority
01/07/2019 – 30/06/2020
AVA Genomics Consultancy ApS (CVR 37493678) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -117 and a net result of DKK -135 compared with DKK 10,088 the year before. Equity in the 2020 report amounted to DKK 9,839. The solvency ratio was 35%.
- Gross Profit
- DKK -117
- Profit/Loss
- DKK -135
- Equity
- DKK 9,839
- Total Assets
- DKK 28,099
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -117 | -135 | 10 t. | 0 |
| 2019 | - | 18 t. | 10 t. | 10 t. | 0 |
| 2018 | - | -2 t. | -2 t. | -114 | 0 |
Official annual report
How creditworthy is AVA Genomics Consultancy ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout AVA Genomics Consultancy ApS
AVA Genomics Consultancy ApS is a Danish company of the type Anpartsselskab based in Randers SV, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named AVA Genomics and Breeding Consultancy IVS. The management consists of Haja Najeemudin Kadarmideen. The company is owned by Haja Najeemudin Kadarmideen. The company has 1 employee (2026). In 2026, the company reported a gross profit of DKK 14,728 and a net result of DKK -4,294 compared with DKK -18,733 the year before. Equity in the 2026 report amounted to DKK 90,595.